| Cat. No. |
Product Name |
Information |
| PC-35530 |
MID-1
MG53-IRS-1 inhibitor
|
MID-1 (ChemBridge5655896) is a specific small molecule MG53-IRS-1 interaction disruptor (MID), but not MG53-FAK and-Cav-3 interaction. |
| PC-35527 |
Qstatin
|
Qstatin is a potent SmcR inhibitor in V. vulnificus. with IC50 of 208.9 nM, shows pan-QS (quorum sensing) inhibitor activity in diverse Vibrio species. |
| PC-35500 |
NMac1
Nm23/NDPK activator
|
NMac1 (Nm23 activator 1) is a small molecule activator of Nm23/NDPK, directly binds to Nm23-H1 and activates NDPK activity of recombinant Nm23-H1 with EC50 of 10.7 uM. |
| PC-35499 |
CFM-4.16
CARP-1 inducer
|
CFM-4.16 is a CARP-1 functional mimetic (CFM) compound bind with CARP-1, stimulates CARP-1 expression and apoptosis. |
| PC-35481 |
JNJ-26489112
Anticonvulsant agent
|
JNJ-26489112 (JNJ26489112) is a broad-spectrum anticonvulsant that displays activity in rodents against audiogenic, electrically-induced, and chemically-induced seizures. |
| PC-35479 |
Padsevonil
SV2 ligand
|
Padsevonil (UCB0942) is an antiepileptic drug (AED) candidate with high affinity for synaptic vesicle 2 (SV2) proteins with pKi of 8.5/7.9/8.5 for SV2A/SV2B/SV2C, respectively. |
| PC-35466 |
Soticlestat
CH24H inhibitor
|
Soticlestat (TAK-935) is a potent, selective, orally active inhibitor for Cholesterol 24-hydroxylase (CH24H) with IC50 of 7.4 nM. |
| PC-35460 |
ATR-101 free base
ACAT1 inhibitor
|
ATR-101 (PD-132301, Nevanimibe) is a selective and potent inhibitor of ACAT1 with IC50 of 52 nM. |
| PC-35451 |
Foslinanib sodium
TRAP1 inhibitor
|
Foslinanib (TRX-818, CVM-1118) sodium is an orally bioavailable agent with potential antineoplastic and anti-vasculogenic mimicry (VM) activities, promotes apoptosis and inhibits vasculogenic mimicry via targeting TRAP1. |
| PC-35441 |
Cimlanod
HNO donor
|
Cimlanod is a second-generation nitroxyl (HNO) donor, delivers HNO via pH-dependent chemical breakdown when exposed to the neutral pH environment of the bloodstream, shows positive lusitropic and inotropic as well as vasodilatory effects. |
| PC-35430 |
BIO124
PICK1-GluA2 inhibitor
|
BIO124 (BIO-124) is a modest inhibitor of the PICK1-GluA2 interaction with IC50 of 0.51 uM in FP assays, binds to the PDZ domain of PICK1. |
| PC-35415 |
Desmethyl dabrafenib
|
Desmethyl dabrafenib (GSK2167542, Dabrafenib metabolite M8) is the desmethyl- metabolic byproduct of Dabrafenib, ameliorates developmental pathologies of Kabuki Syndrome in vivo.. |
